In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...
(Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a ...
MiBolsilloColombia on MSN
Medicare drug price negotiation: 10 drugs cheaper in 2026
Big savings are coming in 2026. See the list of the first 10 drugs with prices negotiated by Medicare, including Eliquis, ...
After years of battling over the patents on blockbuster diabetes drug Januvia, Merck and its generic rival Viatris are ready to put the case to rest. In a recent filing with the U.S. District Court ...
Unichem has obtained tentative approval from the Food and Drug Administration for sitagliptin tablets in dosage strengths of 25 mg, 50 mg, and 100 mg The medication is a generic of Merck Sharpe and ...
Drugmaker Merck & Co. says its experimental Type 2 diabetes drug performed about as well as its older daily pill, Januvia, in a late-stage patient test. The new drug, once-weekly omarigliptin, reduced ...
CHICAGO, June 23 (Reuters) - Merck & Co.'s new diabetes pill, Januvia, improved blood sugar control when added to current therapies, according to data released on Saturday at a major medical meeting.
Biz BriefsA new diabetes treatment from Merck that is expected to ring up big sales received U.S. Food and Drug Administration approval last week. Januvia is a once-a-day pill that will be marketed to ...
Medicare Part D prescription drug plans generally cover prescription drugs like Januvia, which, along with diet and exercise, helps lower blood sugar for people with type 2 diabetes. The cost of ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Diabetics gained a new way of controlling their blood sugar levels Tuesday with the federal approval of a novel pill for Type 2 diabetes, which affects about 20 million Americans. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results